OMG takes pounds 2.5m antibiotics stake
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.OMG takes pounds 2.5m antibiotics stake
OXFORD Molecular Group (OMG), the provider of IT and drug discovery research services to the biotechnology and pharmaceutical industries, is investing pounds 2.5m in MicroGenics, a new company aimed at speeding up the development of antibiotics. The company was formed by Professor Jeff Errington of the University of Oxford. The professor, the university and OMG will have stakes in the company.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments